Medicinova (MNOV) Retained Earnings (2010 - 2025)
Medicinova's (MNOV) quarterly Retained Earnings came in at -$438.7 million in Q4 2025, down 2.81% year-on-year from -$451.4 million in Q4 2024, and down 0.64% on a QoQ basis from -$435.9 million in Q3 2025.
Medicinova (MNOV) Retained Earnings (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Retained Earnings data on file, last reported at -$438.7 million in Q4 2025.
- On a quarterly basis, Retained Earnings fell 2.81% year-over-year to -$438.7 million in Q4 2025; TTM through Dec 2025 was -$438.7 million, a 2.81% decrease from a year earlier, with the FY2025 full-year figure at -$438.7 million, down 2.81% from the prior year.
- Retained Earnings for Q4 2025 stood at -$438.7 million, down from -$435.9 million in the prior quarter.
- Over the last five years, Retained Earnings for MNOV reached as high as -$93677.0 in Q2 2021 and fell as low as -$438.7 million in Q4 2025.
- Historically, Retained Earnings has averaged -$189.1 million across 5 years, with a median of -$129254.5 in 2024.
- Across the five-year window, Retained Earnings surged 99.97% in 2021 and plunged 427407.83% in 2022, its largest moves.
- Year by year, Retained Earnings stood at -$98877.0 in 2021, then decreased by 16.59% to -$115285.0 in 2022, then plunged by 360486.11% to -$415.7 million in 2023, then fell by 2.66% to -$426.8 million in 2024, then dropped by 2.81% to -$438.7 million in 2025.
- Per Business Quant data, the three most recent Retained Earnings figures were -$438.7 million in Q4 2025, -$435.9 million in Q3 2025, and -$432.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | -438.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -438.75 Mn |
| Sep 30, 2025 | -435.95 Mn |
| Jun 30, 2025 | -432.90 Mn |
| Mar 31, 2025 | -429.62 Mn |
| Dec 31, 2024 | -426.75 Mn |
| Sep 30, 2024 | -123,803.00 |
| Jun 30, 2024 | -131,527.00 |
| Mar 31, 2024 | -126,982.00 |
| Dec 31, 2023 | -415.70 Mn |
| Sep 30, 2023 | -123,752.00 |
| Jun 30, 2023 | -121,040.00 |
| Mar 31, 2023 | -116,827.00 |
| Dec 31, 2022 | -115,285.00 |
| Sep 30, 2022 | -404.13 Mn |
| Jun 30, 2022 | -400.48 Mn |
| Mar 31, 2022 | -396.45 Mn |
| Dec 31, 2021 | -98,877.00 |
| Sep 30, 2021 | -95,039.00 |
| Jun 30, 2021 | -93,677.00 |
| Mar 31, 2021 | -95,040.00 |